Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Biologics Appoints Ping Zhang as CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cytovance Biologics Appoints Ping Zhang as CEO

Zhang has over 30 years of experience in manufacturing and operations in the pharmaceutical industry.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics, has appointed Ping Zhang as chief executive officer.
 
In his role as CEO, Zhang provides oversight in the development and execution of the company’s business strategies in the contract manufacturing industry. He holds a Master of Business Administration and serves on the board of other subsidiaries within the Hepalink Group.
 
Zhang has over 30 years of experience in manufacturing and operations in the pharmaceutical industry. He served at Sanofi as the Head of Industry Affairs China for 20 years and was responsible for seven plants across China. Zhang has extensive experience in technical transfer and new product launch at Sanofi China. Prior to that, he served as the Head of Manufacturing at Johnson & Johnson China for 14 years.
 
“At Cytovance, everything we do here is driven by our mission and responsibility to our customers who use our products and services to enable the world to be a healthier, safer, and better place.” said Zhang. “As a biologics CDMO that focuses on development and manufacturing for more than 20 years, we are constantly striving to provide value to customers and patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters